| dc.contributor.author | Anderson, J. | |
| dc.contributor.author | Rousseau, F. | |
| dc.contributor.author | Sorbel, J. | |
| dc.contributor.author | Mondou, E. | |
| dc.contributor.author | Quinn, J. | |
| dc.contributor.author | Marcellin, P. | |
| dc.contributor.author | Jacobson, I. | |
| dc.contributor.author | Habersetzer, F. | |
| dc.contributor.author | Senturk, H. | |
| dc.contributor.author | Andreone, P. | |
| dc.contributor.author | Moyes, C. | |
| dc.contributor.author | Horban, A. | |
| dc.contributor.author | Teuber, G. | |
| dc.date.accessioned | 2021-03-03T10:27:46Z | |
| dc.date.available | 2021-03-03T10:27:46Z | |
| dc.identifier.citation | Marcellin P., Jacobson I., Habersetzer F., Senturk H., Andreone P., Moyes C., Horban A., Teuber G., Sorbel J., Anderson J., et al., "Tenofovir disoproxil fumarate (TDF) for the treatment of HBeAg-negative chronic hepatitis B: Week 72 TDF data and week 24 adefovir dipivoxil switch data (study 102)", 43rd Annual Meeting of the European-Association-for-the-Study-of-the-Liver, Milan, İtalya, 23 - 27 Nisan 2008, cilt.48 | |
| dc.identifier.other | vv_1032021 | |
| dc.identifier.other | av_22b76b86-2b5e-4943-880e-1409433c2500 | |
| dc.identifier.uri | http://hdl.handle.net/20.500.12627/28341 | |
| dc.identifier.uri | https://doi.org/10.1016/s0168-8278(08)60059-8 | |
| dc.language.iso | eng | |
| dc.subject | Dahili Tıp Bilimleri | |
| dc.subject | İç Hastalıkları | |
| dc.subject | Gastroenteroloji-(Hepatoloji) | |
| dc.subject | Tıp | |
| dc.subject | Sağlık Bilimleri | |
| dc.subject | Klinik Tıp (MED) | |
| dc.subject | Klinik Tıp | |
| dc.subject | GASTROENTEROLOJİ VE HEPATOLOJİ | |
| dc.title | Tenofovir disoproxil fumarate (TDF) for the treatment of HBeAg-negative chronic hepatitis B: Week 72 TDF data and week 24 adefovir dipivoxil switch data (study 102) | |
| dc.type | Bildiri | |
| dc.contributor.department | Assistance Publique Hopitaux Paris (APHP) , , | |
| dc.identifier.volume | 48 | |
| dc.contributor.firstauthorID | 134645 | |
